2728 Injunctions in the Post-eBay World: Will Compulsory Licensing and Price Competition Become the New Paradigm for Biologics?
2958 Contract Workshop: Best Practice Indemnification Provisions
3259 The Narrowing Scope of Biotech Patent Claims: What Does It Mean for the Industry?
3317 Launching a Commercial Product: The Key Legal and Regulatory Issues You Need to Know
3479 Preemption of Product Liability Litigation on FDA- Regulated Products
3480 Working within the Post-FDAAA Regulatory System to Mitigate the Risks of Marketing Biopharmaceuticals
3481 Current Challenges in Managing Relationships Between Industry and Physicians
3482 The Unique Role of In-House Pharma/Biotech Lawyers: Legal and Ethical Risks
3484 Shaping Biosimilars Policy: The Interplay of Data Exclusivity, Patient Safety, and Patents
3861 Strategic Considerations in Coordinating Acceleration of International Patent Prosecution